| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 5536510 | Vaccine | 2017 | 7 Pages | 
Abstract
												This decentralised targeted HBV-vaccination program is a cost-effective intervention in certain unvaccinated high-risk adults. Saturation within the risk-groups, participation of individuals with less risky behaviour, and increased recruitment investments in the second period made the program less cost-effective over time. The project should therefore discus how to reduce costs per risk-group, increase effects or when to integrate the vaccination in regular healthcare.
											Related Topics
												
													Life Sciences
													Immunology and Microbiology
													Immunology
												
											Authors
												M.-J.J. Mangen, H. Stibbe, A. Urbanus, E.C. Siedenburg, Q. Waldhober, G.A. de Wit, J.E. van Steenbergen, 
											